Adverse effects of remdesivir, hydroxychloroquine and lopinavir/ritonavir when used for COVID-19: systematic review and meta-analysis of randomised trials

BACKGROUND: To summarise specific adverse effects of remdesivir, hydroxychloroquine and lopinavir/ritonavir in patients with COVID-19. METHODS: We searched 32 databases through 27 October 2020. We included randomised trials comparing any of the drugs of interest to placebo or standard care, or again...

Descripción completa

Detalles Bibliográficos
Autores principales: Izcovich, Ariel, Siemieniuk, Reed Alexander, Bartoszko, Jessica Julia, Ge, Long, Zeraatkar, Dena, Kum, Elena, Qasim, Anila, Khamis, Assem M, Rochwerg, Bram, Agoritsas, Thomas, Chu, Derek K, McLeod, Shelley L, Mustafa, Reem A, Vandvik, Per, Brignardello-Petersen, Romina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Infectious Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895418/
https://www.ncbi.nlm.nih.gov/pubmed/35236729
http://dx.doi.org/10.1136/bmjopen-2020-048502

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895418/
https://www.ncbi.nlm.nih.gov/pubmed/35236729
http://dx.doi.org/10.1136/bmjopen-2020-048502

Ejemplares similares